atropine sulfate
Sensory organs (S01)US regulatory status: approved. Molecular target: Muscarinic acetylcholine receptor M1.
- Target
- Muscarinic acetylcholine receptor M1
- Mechanism
- Muscarinic acetylcholine receptor M3 antagonist
pharma · Osteoarthritis of the Knee
CellSeed Europe
CellSeed Europe Ltd
CellSeed Europe drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
GB HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- GB
- Programs
- 1
- Drugs
- 1
- Patents
- 0
CellSeed Europe pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
CellSeed Europe drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.